HOME >> MEDICINE >> NEWS
HIV testing should be routine part of primary health care for sexually active

om 1999 to 2002 were acquired heterosexually. Since the early 1980s, the proportion of people acquiring HIV infection through heterosexual transmission has continued to increase relative to other methods of transmission. Approximately 250,000 people in the United States infected with HIV do not know they are infected, according to the Foundation for Retrovirology and Human Health.

"Based on an extensive review of the current state of HIV infection, we believe an immediate change to routine voluntary testing is a necessary and critical step to reduce HIV infection and prevent AIDS in this country," says Carlos del Rio, professor of medicine at Emory University School of Medicine, chief of medical services at Atlanta's Grady Memorial Hospital and one of the study authors. "We are missing opportunities to diagnose HIV infection before individuals develop AIDS, when we can offer counseling about secondary prevention and risky behaviors, begin antiretroviral therapy and help prevent opportunistic infections."

Current recommendations for testing in high-prevalence areas (where HIV infection is greater than one percent) and testing based on risk assessment are impractical and inaccurate, the research team reports. Most health care providers do not have access to estimates about prevalence in their particular area, and often it is difficult to determine the risk of HIV infection in individual patients. Smaller social networks with a high prevalence of infection also can be part of a larger community where prevalence is low, making accurate risk assessment more difficult.

"Many people who engage in risky behaviors are reluctant to tell their healthcare providers and may not request HIV testing," says del Rio. "People infected through heterosexual transmission, particularly adolescents, often do not consider themselves to be at risk and do not seek testing on their own. Health care providers also may not elicit accurate information about risk. Routine
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
30-Mar-2005


Page: 1 2 3

Related medicine news :

1. HIV testing should no longer be accorded any special status
2. Dual testing better for monitoring new cases of HIV
3. Disease testing for immigrants: Discrimination disguised as public health policy
4. Americans support most uses of reproductive genetic testing, report on US attitudes reveals
5. Chlamydia testing in pharmacies: Questions that need addressing
6. Rush University Medical Center testing magnetic stimulation for depression
7. Northwestern Memorial Hospital testing new procedure for patients with major depression
8. Genetic testing can identify ischemic and nonischemic heart failure
9. Genetics testing saves health care dollars
10. Spread of HIV could slow if repeat testing is supported
11. Data announced at ISHLT: Molecular testing proves effective in monitoring heart transplant rejection

Post Your Comments:
(Date:5/20/2013)... (PRWEB) May 20, 2013 This summer, ... the world will make the pilgrimage to San Diego, ... annual Digital Health Summer Summit produced by ... a unique forum to showcase the latest digital health ... practices, and network with some of industry’s most brilliant ...
(Date:5/20/2013)... May 20, 2013 For more than ... waged a battle against drug and alcohol abuse around ... released its first guide to help Italian speakers reverse ... by the European Monitoring Centre for Drugs and Drug ... have used cannabis in the last year. As a ...
(Date:5/20/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) -- ... out in the late 1990s is more effective than ... contends. Teenagers who received four shots with the ... were 2 years old were significantly less likely to ... in California, compared to children who received all of ...
(Date:5/20/2013)... What is it about toothpaste that transforms the sweet ... the solution to that mysterious sensory phenomenon in ... the American Chemical Society,s award-winning Bytesize Science ... from the world,s largest scientific society, explains that the ... lauryl sulfate, or SLS for short. When you brush ...
(Date:5/20/2013)... MAYWOOD, Il. - Nearly three out of ... disorders during their pregnancies, a Loyola University Medical Center ... only minimal impacts on pregnant women,s quality of life, ... Scott Graziano, MD and Payton Johnson was presented during ... Clinical Meeting in New Orleans. , One hundred and ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2Health News:Study: Older Whooping Cough Vaccine More Effective 2Health News:Study: Older Whooping Cough Vaccine More Effective 3Health News:72 percent of pregnant women experience constipation and other bowel problems 2
(Date:5/20/2013)... 2013  AbbVie (NYSE: ABBV ) ... clinical study called SONAR (Study Of Diabetic Nephropathy ... investigational compound atrasentan - when added to standard of ... with stage 2 to 4 chronic kidney disease ... large, multinational, double-blind, placebo-controlled clinical study that is ...
(Date:5/19/2013)... ORLANDO, Fla. , May 19, 2013 /PRNewswire/ ... power and low temperature radiofrequency (RF) energy is ... and eliminates or reduces the need for medication ... long-term assessment presented today at the Digestive Disease ... Orlando, Florida . ...
(Date:5/17/2013)... SHANGHAI , May 17, 2013 Medical ... drug nor a biological product. In light of their ... trail evaluations are much more complicated than drug trails ... only evaluates MD safety instead of evaluating both safety ... the US FDA (which is the same as the ...
Breaking Medicine Technology:AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Statistical Challenges in Medical Device Trail Evaluation 2
Cached News: